What do systematic reviews say?

Intervention not reported

It is very uncertain whether the intervention changes adverse events: hypersensitivity (very low certainty).

• Interleukin‐2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission 2015 · Cochrane Headline outcomes only
  RR 17.13 [0.99, 295.26]
  1 study · 528 participants
  Very low